共 24 条
Regulation of ER molecular chaperone prevents bone loss in a murine model for osteoporosis
被引:58
作者:
Hino, Shin-ichiro
[1
]
Kondo, Shinichi
[1
]
Yoshinaga, Kazuya
[1
]
Saito, Atsushi
[1
]
Murakami, Tomohiko
[1
]
Kanemoto, Soshi
[1
]
Sekiya, Hiroshi
[1
]
Chihara, Kazuyasu
[1
]
Aikawa, Yuji
[1
]
Hara, Hideaki
[2
]
Kudo, Takashi
[3
]
Sekimoto, Tomohisa
[4
]
Funamoto, Taro
[4
]
Chosa, Etsuo
[4
]
Imaizumi, Kazunori
[1
]
机构:
[1] Miyazaki Univ, Fac Med, Dept Anat, Div Mol & Cellular Biol, Miyazaki 8891692, Japan
[2] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu 5028585, Japan
[3] Osaka Univ, Grad Sch Med, Dept Clin Neurosci, Suita, Osaka 5650871, Japan
[4] Miyazaki Univ, Fac Med, Dept Orthopaed Surg, Miyazaki 8891692, Japan
关键词:
Osteoporosis;
Osteoblast;
BiP;
BIX;
Endoplasmic reticulum stress response;
UNFOLDED-PROTEIN RESPONSE;
ENDOPLASMIC-RETICULUM;
TRANSLATIONAL CONTROL;
STRESS;
DISEASES;
MARROW;
KINASE;
MOUSE;
D O I:
10.1007/s00774-009-0117-z
中图分类号:
R5 [内科学];
学科分类号:
100201 [内科学];
摘要:
Endoplasmic reticulum (ER) stress response is important for protein maturation in the ER. Some murine models for bone diseases have provided significant insight into the possibility that pathogenesis of osteoporosis is related to ER stress response of osteoblasts. We examined a possible correlation between osteoporosis and ER stress response. Bone specimens from 8 osteoporosis patients and 8 disease-controls were used for immunohistochemical analysis. We found that ER molecular chaperones, such as BiP (immunoglobulin heavy-chain binding protein) and PDI (protein-disulfide isomerase) are down-regulated in osteoblasts from osteoporosis patients. Based on this result, we hypothesized that up-regulation of ER molecular chaperones in osteoblasts could restore decreased bone formation in osteoporosis. Therefore, we investigated whether treatment of murine model for osteoporosis with BIX (BiP inducer X), selective inducer BiP, could prevent bone loss. We found that oral administration of BIX effectively improves decline in bone formation through the activation of folding and secretion of bone matrix proteins. Considering these results together, BIX may be a potential therapeutic agent for the prevention of bone loss in osteoporosis patients.
引用
收藏
页码:131 / 138
页数:8
相关论文

